ロード中...
Musashi2 sustains the mixed-lineage leukemia–driven stem cell regulatory program
Leukemia stem cells (LSCs) are found in most aggressive myeloid diseases and contribute to therapeutic resistance. Leukemia cells exhibit a dysregulated developmental program as the result of genetic and epigenetic alterations. Overexpression of the RNA-binding protein Musashi2 (MSI2) has been previ...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4362230/ https://ncbi.nlm.nih.gov/pubmed/25664853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI78440 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|